Literature DB >> 20829330

New strategies in ovarian cancer: uptake and experience of women at high risk of ovarian cancer who are considering risk-reducing salpingo-oophorectomy.

Suzanne M Miller1, Pagona Roussi, Mary B Daly, John Scarpato.   

Abstract

Here, we review factors associated with uptake of risk-reducing salpingo-oophorectomy by women at increased hereditary risk for ovarian cancer, as well as quality of life issues following surgery. Forty-one research studies identified through PubMed and PsychInfo met inclusion criteria. Older age, having had children, a family history of ovarian cancer, a personal history of breast cancer, prophylactic mastectomy, and BRCA1/2 mutation carrier status increase the likelihood of undergoing surgery. Psychosocial variables predictive of surgery uptake include greater perceived risk of ovarian cancer and cancer-related anxiety. Most women report satisfaction with their decision to undergo surgery and both lower perceived ovarian cancer risk and less cancer-related anxiety as benefits. Hormonal deprivation is the main disadvantage reported, particularly by premenopausal women who are not on hormonal replacement therapy (HRT). The evidence is mixed about satisfaction with the level of information provided prior to surgery, although generally, women report receiving insufficient information about the pros and cons of HRT. These findings indicate that when designing decision aids, demographic, medical history, and psychosocial variables need to be addressed in order to facilitate quality decision making. ©2010 AACR.

Entities:  

Mesh:

Year:  2010        PMID: 20829330      PMCID: PMC3107031          DOI: 10.1158/1078-0432.CCR-09-2953

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  54 in total

1.  A qualitative study of the information needs of high-risk women undergoing prophylactic oophorectomy.

Authors:  N Hallowell
Journal:  Psychooncology       Date:  2000 Nov-Dec       Impact factor: 3.894

Review 2.  Predictors of choosing life-long screening or prophylactic surgery in women at high and moderate risk for breast and ovarian cancer.

Authors:  J R J De Leeuw; M J van Vliet; M G E M Ausems
Journal:  Fam Cancer       Date:  2008-03-14       Impact factor: 2.375

Review 3.  Oophorectomy for breast cancer prevention in women with BRCA1 or BRCA2 mutations.

Authors:  Kelly A Metcalfe
Journal:  Womens Health (Lond)       Date:  2009-01

Review 4.  Decision making and decision support for hereditary breast-ovarian cancer susceptibility.

Authors:  Marc D Schwartz; Beth N Peshkin; Kenneth P Tercyak; Kathryn L Taylor; Heiddis Valdimarsdottir
Journal:  Health Psychol       Date:  2005-07       Impact factor: 4.267

5.  Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.

Authors:  Anne Uyei; Susan K Peterson; Julie Erlichman; Kristine Broglio; Sandra Yekell; Kathkeen Schmeler; Karen Lu; Funda Meric-Bernstam; Chris Amos; Louise Strong; Banu Arun
Journal:  Cancer       Date:  2006-12-15       Impact factor: 6.860

6.  Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.

Authors:  Noah D Kauff; Jaya M Satagopan; Mark E Robson; Lauren Scheuer; Martee Hensley; Clifford A Hudis; Nathan A Ellis; Jeff Boyd; Patrick I Borgen; Richard R Barakat; Larry Norton; Mercedes Castiel; Khedoudja Nafa; Kenneth Offit
Journal:  N Engl J Med       Date:  2002-05-20       Impact factor: 91.245

7.  Increased cardiovascular mortality after early bilateral oophorectomy.

Authors:  Cathleen M Rivera; Brandon R Grossardt; Deborah J Rhodes; Robert D Brown; Véronique L Roger; L Joseph Melton; Walter A Rocca
Journal:  Menopause       Date:  2009 Jan-Feb       Impact factor: 2.953

8.  Climacteric symptoms in women undergoing risk-reducing bilateral salpingo-oophorectomy.

Authors:  A Benshushan; N Rojansky; M Chaviv; S Arbel-Alon; A Benmeir; T Imbar; A Brzezinski
Journal:  Climacteric       Date:  2009-10       Impact factor: 3.005

9.  International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.

Authors:  Kelly A Metcalfe; Daphna Birenbaum-Carmeli; Jan Lubinski; Jacek Gronwald; Henry Lynch; Pal Moller; Parviz Ghadirian; William D Foulkes; Jan Klijn; Eitan Friedman; Charmaine Kim-Sing; Peter Ainsworth; Barry Rosen; Susan Domchek; Teresa Wagner; Nadine Tung; Siranoush Manoukian; Fergus Couch; Ping Sun; Steven A Narod
Journal:  Int J Cancer       Date:  2008-05-01       Impact factor: 7.396

Review 10.  Prophylactic oophorectomy in premenopausal women and long-term health.

Authors:  Lynne T Shuster; Bobbie S Gostout; Brandon R Grossardt; Walter A Rocca
Journal:  Menopause Int       Date:  2008-09
View more
  21 in total

1.  Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: An NRG Oncology/Gynecologic Oncology Group study.

Authors:  Phuong L Mai; Marion Piedmonte; Paul K Han; Richard P Moser; Joan L Walker; Gustavo Rodriguez; John Boggess; Thomas J Rutherford; Oliver Zivanovic; David E Cohn; J Tate Thigpen; Robert M Wenham; Michael L Friedlander; Chad A Hamilton; Jamie Bakkum-Gamez; Alexander B Olawaiye; Martee L Hensley; Mark H Greene; Helen Q Huang; Lari Wenzel
Journal:  Gynecol Oncol       Date:  2017-02-10       Impact factor: 5.482

Review 2.  Risk-Reducing Strategies for Ovarian Cancer in BRCA Mutation Carriers: A Balancing Act.

Authors:  Roi Tschernichovsky; Annekathryn Goodman
Journal:  Oncologist       Date:  2017-03-17

3.  The impact of risk-reducing gynaecological surgery in premenopausal women at high risk of endometrial and ovarian cancer due to Lynch syndrome.

Authors:  Ramona Moldovan; Sianan Keating; Tara Clancy
Journal:  Fam Cancer       Date:  2015-03       Impact factor: 2.375

4.  Factors associated with altered long-term well-being after prophylactic salpingo-oophorectomy among women at increased hereditary risk for breast and ovarian cancer.

Authors:  Cyril Touboul; Catherine Uzan; Jean Laurent Ichanté; Olivier Caron; Ariane Dunant; Sarah Dauchy; Sébastien Gouy; Brigitte Bressac de Paillerets; Philippe Morice; Suzette Delaloge
Journal:  Oncologist       Date:  2011-07-17

5.  Cancer risk management in Tasmanian women with BRCA1 and BRCA2 mutations.

Authors:  Stephanie Kearton; Karen Wills; Michael Bunting; Penny Blomfield; Paul A James; Jo Burke
Journal:  Fam Cancer       Date:  2018-07       Impact factor: 2.375

6.  Looking different, feeling different: women's reactions to risk-reducing breast and ovarian surgery.

Authors:  Nina Hallowell; Brandi Baylock; Louise Heiniger; Phyllis N Butow; Deepa Patel; Bettina Meiser; Christobel Saunders; Melanie A Price
Journal:  Fam Cancer       Date:  2012-06       Impact factor: 2.375

7.  Catalysts to withdrawal from familial ovarian cancer screening for surgery and reactions to discontinued screening: a qualitative study.

Authors:  Kate J Lifford; Alison Clements; Lindsay Fraser; Deborah Lancastle; Kate Brain
Journal:  Fam Cancer       Date:  2013-03       Impact factor: 2.375

8.  Quality of life following prophylactic gynecological surgery: experiences of female Lynch mutation carriers.

Authors:  Holly Etchegary; Elizabeth Dicks; Laura Tamutis; Lesa Dawson
Journal:  Fam Cancer       Date:  2018-01       Impact factor: 2.375

9.  Talking about women's sexual health after cancer: Why is it so hard to move the needle?

Authors:  Jennifer Barsky Reese; Sharon L Bober; Mary B Daly
Journal:  Cancer       Date:  2017-11-08       Impact factor: 6.860

10.  Psychosocial factors and uptake of risk-reducing salpingo-oophorectomy in women at high risk for ovarian cancer.

Authors:  Bettina Meiser; Melanie A Price; Phyllis N Butow; Janan Karatas; Judy Wilson; Louise Heiniger; Brandi Baylock; Margaret Charles; Sue-Anne McLachlan; Kelly-Anne Phillips
Journal:  Fam Cancer       Date:  2013-03       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.